About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

WITHDRAWNNA

Efficacy of Zinc Supplementation on Botox Treated Forehead Rhytids

NCT05894109•University of New Mexico

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Adjuvant Zinc May Increase the Efficacy of Botulinum ToxinZinc Supplementation for Botulinum Toxin Treatment of the ForeheadGlabellar Frown Lines+2 more

Interventions

zinc citrate 50 mg

Placebo Microcrystalline Cellulose

Key Dates

Start Date

August 1, 2024

Primary Completion Date

October 1, 2024

Completion Date

October 1, 2024

Last Updated

September 19, 2024

Related Studies

Active Not Recruiting

Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines

NCT05481931

Glabellar Frown Lines

COMPLETEDPhase 3

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII)

NCT03985982

Glabellar Frown Lines

COMPLETEDPhase 2

Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar Lines

NCT06411002

Glabellar Frown Lines

COMPLETEDPhase 3

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

NCT05146999

Glabellar Frown Lines

COMPLETEDPhase 3

Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

NCT05148000

Glabellar Frown LinesCanthal Lines

COMPLETEDPhase 4

Study Comparing Treatment With Alluzience vs Reconstituted Toxin

NCT05277337

Glabellar Frown Lines

View all related studies

Sponsors

Lead Sponsor

University of New Mexico

Collaborators

AbbVie

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 19, 2024Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions